Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.670 +0.070 (+4.37%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
Via FinancialNewsMedia
News headline image
Looking Into Inovio Pharmaceuticals's Return On Capital Employed ↗
Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting... 
Via Benzinga
News headline image
Etsy And NetApp Lead The S&P 500 ↗
U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and... 
Via Benzinga
Topics Economy Stocks
Analyzing Inovio Pharmaceuticals's Unusual Options Activity ↗
Inovio Pharmaceuticals (NASDAQ:INO) shares experienced unus... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
Why Inovio Stock Is Jumping Today ↗
The vaccine maker received some good news from Brazil. 
Via The Motley Fool
News headline image
Inovio Pharmaceuticals Stock Nears End Of Technical Pattern ↗
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading... 
Via Benzinga
News headline image
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial ↗
The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-... 
Via Benzinga
News headline image
Why Inovio's Stock Is Trading Higher Today ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the... 
Via Benzinga
News headline image
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money ↗
Not every stock on the popular trading app is worth owning. 
Via The Motley Fool
News headline image
Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines. 
Via The Motley Fool
News headline image
Unusual Options Activity Insight: Inovio Pharmaceuticals ↗
On Wednesday, shares of Inovio Pharmaceuticals (NASDAQ:INO) saw unusual options activity. After the option alert, the stock price moved down to $8.29. Sentiment: BULLISH Option... 
Via Benzinga
News headline image
3 Scary COVID Stocks to Avoid ↗
Our Fool roundtable picks three COVID stocks they think are dangerous at these prices. 
Via The Motley Fool
News headline image
Apple And Salesforce Lead The DIA In A Mixed Day Of Trading ↗
U.S. indices had a mixed day of trading Thursday as traders and investors weigh COVID-19 variant updates, recent earnings and the recently passed $1 trillion... 
Via Benzinga
News headline image
77 Biggest Movers From Yesterday ↗
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
News headline image
Watch Out: Inovio Pharmaceuticals Is Heating Up ↗
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta... 
Via Benzinga
News headline image
85 Biggest Movers From Yesterday ↗
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
Via Benzinga
News headline image
Why Inovio Pharmaceuticals Is Plunging Today ↗
Solid business developments did not please investors. 
Via The Motley Fool
News headline image
Why Inovio's Stock Is Trading Lower Today ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results.... 
Via Benzinga
News headline image
54 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript ↗
INO earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Recap: Inovio Pharmaceuticals Q2 Earnings ↗
Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year... 
Via Benzinga
News headline image
Why Inovio Stock Is Jumping Today ↗
Chinese regulators approved the initiation of two new clinical studies featuring Inovio's COVID-19 vaccine candidate, INO-4800. 
Via The Motley Fool
News headline image
What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock? ↗
Its vaccine candidate might be too far behind to matter. 
Via The Motley Fool
News headline image
Is Inovio Pharmaceuticals Primed For a Comeback? ↗
The past 12 months have been tough on the vaccine maker. 
Via The Motley Fool
News headline image
Here's Why Inovio Pharmaceuticals Soared 23% In June ↗
Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech. 
Via The Motley Fool
News headline image
Earnings Scheduled For August 9, 2021 ↗
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 ↗
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
News headline image
Inovio Pharmaceuticals: Return On Capital Employed Insights ↗
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... 
Via Benzinga
News headline image
Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships ↗
Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.